Signos raised $20 million to broaden its glucose monitoring platform for weight reduction, which pairs Dexcom’s over-the-counter CGM with an app that interprets glucose knowledge into customized weight loss plan and way of life suggestions.
The put up Signos Secures $20M to Develop CGM Use Past Diabetes Into Weight Loss appeared first on MedCity Information.
